Oxford BioDynamics Plc (LON:OBD – Get Free Report)’s share price reached a new 52-week low during trading on Thursday . The stock traded as low as GBX 0.17 and last traded at GBX 0.19, with a volume of 1788537 shares changing hands. The stock had previously closed at GBX 0.19.
Oxford BioDynamics Stock Performance
The company has a market capitalization of £8.15 million, a PE ratio of -0.24 and a beta of 0.42. The company has a debt-to-equity ratio of 457.97, a quick ratio of 2.80 and a current ratio of 0.88. The company has a 50 day moving average price of GBX 0.22 and a 200 day moving average price of GBX 0.25.
Oxford BioDynamics Company Profile
Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.
In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.
Read More
- Five stocks we like better than Oxford BioDynamics
- YETI Rallies After Earnings Beat and Raised Outlook
- How the 3 Leading Quantum Firms Stack Up After Q1 Earnings
- Cisco’s Vertical Rally May Still Be in the Early Innings
- Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.
